MGH Diabetes Center is a clinical research site located in Boston, Massachusetts, United States 02114.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
MGH Diabetes Center has participated in 1 clinical trials.
Therapeutic areas: Diabetes Mellitus, Type 1.
Sponsors: Zealand Pharma.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
MGH Diabetes Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
MGH Diabetes Center has 1 clinical trials on record. Their work covers Diabetes Mellitus, Type 1.
MGH Diabetes Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.